Not logged in.png)
Share.png)
SaveShare Save Share Save A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer
Tahara, Makoto; Takami, Hiroshi; Ito, Yasuhiro; Okamoto, Takahiro; Sugitani, Iwao; Sugino, Kiminori; Takahashi, Shunji; Takeyama, Hiroshi; Tsutsui, Hidemitsu; Hara, Hisato; Mitsuma, Ayako; Yamashita, Hiroyuki; Ohashi, Yasuo; Imai, Tsuneo Share Save Share Save Share Save ATM Mediates pRB Function To Control DNMT1 Protein Stability and DNA MethylationShamma, Awad; Suzuki, Misa; Hayashi, Naoyuki; Kobayashi, Masahiko; Sasaki, Nobunari; Nishiuchi, Takumi; Doki, Yuichiro; Okamoto, Takahiro; Kohno, Susumu; Muranaka, Hayato; Kitajima, Shunsuke; Yamamoto, Ken-ichi; Takahashi, Chiaki Share Save Analysis of the COLLECT Study - Efficacy and safety of lenvatinib in differentiated thyroid cancerIwasaki, Hiroyuki; Takami, Hiroshi; Yasuhiro, Ito; Takahiro, Okamoto; Iwao, Sugitani; Kiminori, Sugino; Shunji, Takahashi; Hiroshi, Takeyama; Hidemitsu, Tutui; Hisato, Hara; Ayako, Mitsuma; Hiroyuki, Yamashita; Yasuo, Ohashi; Takeru, Shiroiwa; Tuneo, Imai; Makoto, Tahara Share Save Share Save Share Save Share Save Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau DiseaseFlores, Shahida K.; Cheng, Ziming; Jasper, Angela M.; Natori, Keiko; Okamoto, Takahiro; Tanabe, Akiyo; Gotoh, Koro; Shibata, Hirotaka; Sakurai, Akihiro; Nakai, Takuya; Wang, Xiaojing; Zethoven, Magnus; Balachander, Shiva; Aita, Yuichi; Young, William, Jr.; Zheng, Siyuan; Takekoshi, Kazuhiro; Nakamura, Eijiro; Tothill, Richard W.; Aguiar, Ricardo C. T.; Dahia, Patricia L. M. Share Save Share Save SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDYUchino, Keita; Komoda, Masato; Tomomatsu, Junichi; Okamoto, Takahiro; Horiuchi, Kiyomi; Tsuji, Akihito; Ito, Yasuhiro; Todo, Takuya; Rito, Ki; Takahashi, Shunji Share Save Real-time in-vivo image-guided cell-cycle perturbation to increase tumor chemosensitivityYano, Shuya; Tazawa, Hiroshi; Kishimoto, Hiroyuki; Kagawa, Shunsuke; Kadowaki, Yoshihiko; Ishido, Nobuhiro; Okamoto, Takahiro; Urata, Yasuo; Takehara, Kiyoto; Hoffman, Robert M.; Fujiwara, Toshiyoshi Share Save A triplet combination with oxaliplatin/capecitabine/irinotecan (XELOXIRI) plus cetuximab (Cmab) as a first-line therapy in wild-type KRAS, metastatic colorectal cancer: a dose escalating studySato, Y.; Ohnuma, H.; Hirakawa, M.; Kikuch, S.; Takahashi, M.; Okamoto, T.; Tsuji, Y.; Okita, K.; Furuhata, T.; Takemasa, I.; Kato, J. Share Save Share Save Share Save Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptionsSakurai, Akihiro; Imai, Tsuneo; Kikumori, Toyone; Horiuchi, Kiyomi; Okamoto, Takahiro; Uchino, Shinya; Kosugi, Shinji; Suzuki, Shinichi; Suyama, Keiko; Yamazaki, Masanori; Sato, Ai Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
